| Date | Case | Cited by |
|---|---|---|
| 18 Dec 2015 |
[2015] EWHC 3973 (Pat)
In deciding patent litigation costs, the court must identify the overall winner by examining the substance and reality of the dispute. Different outcomes…
|
1 |
| 15 Dec 2015 |
[2015] EWHC 3596 (Pat)
Permission to serve proceedings out of the jurisdiction requires a serious issue to be tried on the merits, a good arguable case for the relevant…
|
|
| 25 Nov 2015 |
[2015] EWHC 3370 (Pat)
A post-trial application to rewrite patent claims may constitute an abuse of process where the amendment could and should have been sought before trial and…
|
|
| 23 Nov 2015 |
[2015] EWHC 3366 (Pat)
Patent claims are construed according to the meaning which a skilled person would give them in context. General claim language is not narrowed merely because…
|
4 |
| 20 Nov 2015 |
[2015] EWHC 3298 (Pat)
Patent claims must be construed purposively by asking what the skilled person would understand the patentee to mean in context. A claim requiring a fusible…
|
|
| 16 Nov 2015 |
[2015] EWHC 3294 (Pat)
For a second medical use claim, therapeutic efficacy is a functional technical feature. The claimed treatment need not succeed in every patient, but the…
|
4 |
| 12 Nov 2015 |
[2015] EWHC 3302 (Pat)
The court may give judgment on admissions where the admission is contained in written material, including pleadings and expert evidence, and is confirmed in…
|
|
| 4 Nov 2015 |
[2015] EWHC 3163 (Pat)
In a patent action, obviousness is assessed by asking whether the claimed invention, viewed without hindsight, was obvious to the skilled but unimaginative…
|
|
| 4 Nov 2015 |
[2015] EWHC 3153 (Pat)
On an application for an interim patent injunction, the court should adopt the course likely to cause the least irremediable prejudice. The assessment must…
|
|
| 22 Oct 2015 |
[2015] EWHC 2973 (Pat)
For purpose-limited medical-use claims, plausibility is not a free-standing statutory requirement. It is relevant to whether the disclosure is enabling and, in…
|
4 |
| 2 Oct 2015 |
[2015] EWHC 2752 (Pat)
Summary judgment on patent infringement may be appropriate where the court has the necessary evidence and the issue can fairly be decided summarily. However…
|
1 |
| 16 Sep 2015 |
[2015] EWHC 2863 (Pat)
In an issues-based costs assessment, the court should identify the overall winner and decide whether a lost issue is sufficiently distinct to justify depriving…
|
|
| 10 Sep 2015 |
[2015] EWHC 2548 (Pat)
A Swiss-form second medical use claim is a process claim directed to the manufacturer. The word “for” requires a mental link between manufacture and…
|
8 |
| 21 Jul 2015 |
[2015] EWHC 2097 (Pat)
A transfer of standard-essential patents does not infringe Art 101 TFEU merely because the transferee gives a fresh FRAND undertaking rather than assuming the…
|
|
| 20 Jul 2015 |
[2015] EWHC 2114 (Pat)
A patent for operating a pitch-controlled wind turbine was invalid for lack of inventive step. A skilled person applying a prior-art proposal for gradually…
|
|
| 24 Jun 2015 |
[2015] EWHC 1796 (Pat)
A purpose-limited therapeutic claim is not anticipated merely because prior art discloses a proposed or ongoing clinical trial. The claimed therapeutic effect…
|
2 |
| 4 Jun 2015 |
[2015] EWHC 1553 (Pat)
Where defendants have overall success in patent litigation, the starting point is that they receive their costs. The court may make deductions for issues on…
|
|
| 21 May 2015 |
[2015] EWHC 1395 (Pat)
Novelty requires both disclosure and enablement. The prior art must disclose subject matter which would necessarily infringe the claim. A possibility or choice…
|
|
| 5 May 2015 |
[2015] EWHC 1198 (Pat)
In case management, the court may select a fixed service date where that provides greater certainty than linking service to another procedural event. The date…
|
|
| 28 Apr 2015 |
[2015] EWHC 1094 (Pat)
Pre-action disclosure may be ordered to assist settlement and save costs where the jurisdictional conditions in CPR rule 31.16 are satisfied. In patent…
|
1 |
| 27 Apr 2015 |
[2015] EWHC 1068 (Pat)
A patent claim directed to rivastigmine administered transdermally at a specified starting dose contained added matter where the application presented the…
|
|
| 24 Apr 2015 |
[2015] EWHC 1034 (Pat)
A patent claim must be construed purposively, but deliberate claim limitations remain legally significant. A “bit pattern” means a predetermined-length…
|
2 |
| 24 Apr 2015 |
[2015] EWHC 1029 (Pat)
Applications for summary judgment or strike-out concerning FRAND licensing obligations for standard-essential patents should not be determined summarily where…
|
1 |
| 23 Mar 2015 |
[2015] EWHC 818 (Pat)
A product and process description must contain full particulars sufficient to enable the infringement issues to be resolved. It must be complete in all…
|
2 |
| 2 Mar 2015 |
[2015] EWHC 485 (Pat)
The court may grant an injunction under section 37(1) of the Senior Courts Act 1981 to require a third party to take proportionate protective measures where…
|
|
| 6 Feb 2015 |
[2015] EWHC 249 (Pat)
A Swiss form claim is a process claim. It cannot be treated as an EPC 2000 product claim, or as equivalent to one, for the purposes of indirect infringement.…
|
|
| 6 Feb 2015 |
[2015] EWHC 223 (Pat)
Where infringement depends on a developing and unsettled question of patent law, the court may refuse strike-out or summary judgment and require the facts to…
|
|
| 30 Jan 2015 |
[2015] EWHC 214 (Pat)
Before an order is drawn up and sealed, the court has jurisdiction to reopen a judgment and permit amended pleadings, fresh evidence and a further trial. The…
|
7 |
| 21 Jan 2015 |
[2015] EWHC 72 (Pat)
A Swiss-form second medical use claim requires subjective intention by the manufacturer that the medicament will be used for the specified therapeutic…
|
2 |